Cellect Biotechnology Stock Forecast, Price & News

Cellect Biotechnology (NASDAQ:APOP) Frequently Asked Questions

How were Cellect Biotechnology's earnings last quarter?

Cellect Biotechnology Ltd. (NASDAQ:APOP) released its quarterly earnings results on Tuesday, November, 13th. The company reported ($0.58) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.56) by $0.02.
View Cellect Biotechnology's earnings history.

When did Cellect Biotechnology's stock split? How did Cellect Biotechnology's stock split work?

Shares of Cellect Biotechnology split before market open on Tuesday, October 26th 2021. The 2-1 split was announced on Tuesday, October 26th 2021. The newly minted shares were distributed to shareholders after the market closes on Tuesday, October 26th 2021. An investor that had 100 shares of Cellect Biotechnology stock prior to the split would have 200 shares after the split.

Who are Cellect Biotechnology's key executives?

Cellect Biotechnology's management team includes the following people:

• Shai Yarkoni, Chief Executive Officer & Director
• Amos Ofer, Chief Operating Officer
• Yaron Ben-Oz, Chief Financial Officer

Who are some of Cellect Biotechnology's key competitors?

Some companies that are related to Cellect Biotechnology include STRATA Skin Sciences (SSKN), NeuroMetrix (NURO), Neovasc (NVCN), Daxor (DXR), Universal Media Group (UMGP), INVO Bioscience (INVO), Aethlon Medical (AEMD), Biostage (BSTG), ReShape Lifesciences (RSLS), PetVivo (PETV), Vivos (RDGL), InspireMD (NSPR), Arch Therapeutics (ARTH), Sigyn Therapeutics (SIGY) and NeuroOne Medical Technologies (NMTC).
View all of APOP's competitors.

What other stocks do shareholders of Cellect Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cellect Biotechnology investors own include Elbit Systems (ESLT), Gilead Sciences (GILD), Protalix BioTherapeutics (PLX), Pluristem Therapeutics (PSTI), NVIDIA (NVDA), Teva Pharmaceutical Industries (TEVA), Acasti Pharma (ACST), Allergan (AGN), Novavax (NVAX) and RedHill Biopharma (RDHL).

What is Cellect Biotechnology's stock symbol?

Cellect Biotechnology trades on the NASDAQ under the ticker symbol "APOP."

Who are Cellect Biotechnology's major shareholders?

Cellect Biotechnology's stock is owned by a number of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (3.71%) and Geode Capital Management LLC (1.33%).

Which major investors are selling Cellect Biotechnology stock?

APOP stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC.

Which major investors are buying Cellect Biotechnology stock?

APOP stock was acquired by a variety of institutional investors in the last quarter, including Geode Capital Management LLC.

What is Cellect Biotechnology's stock price today?

One share of APOP stock can currently be purchased for approximately $13.17.

How much money does Cellect Biotechnology make?

Cellect Biotechnology has a market capitalization of $12.87 million.

How many employees does Cellect Biotechnology have?

Cellect Biotechnology employs 2,020 workers across the globe.

What is Cellect Biotechnology's official website?

The official website for Cellect Biotechnology is www.cellect.co.

Where are Cellect Biotechnology's headquarters?

Cellect Biotechnology is headquartered at 23 HATA`AS STREET, KFAR SABA L3, 44425.

How can I contact Cellect Biotechnology?

Cellect Biotechnology's mailing address is 23 HATA`AS STREET, KFAR SABA L3, 44425. The company can be reached via phone at (729) 974-1444, via email at [email protected], or via fax at 972-9767-8750.